EGFR and central nervous system cancer: Key findings in glioma patients in relation to m6A ‘readers’ include YTHDF2 overexpression, induced through the EGFR/SRC/ERK pathway to promote tumourigenesis, invasiveness, and cell proliferation independently associated with poor prognosis [198].